Items where authors include "Srinivasan, R"

Article

Brown, JE, Royle, K-L orcid.org/0000-0003-0225-1199, Gregory, W et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Giannetti, V orcid.org/0000-0001-5703-789X and Srinivasan, R (2022) Corporate lobbying and product recalls: an investigation in the U.S. medical device industry. Journal of the Academy of Marketing Science, 50 (5). pp. 941-960. ISSN 0092-0703

Abbott, R, Abbott, TD, Acernese, F et al. (1656 more authors) (2022) Narrowband searches for continuous and long-duration transient gravitational waves from known pulsars in the LIGO-Virgo third observing run. The Astrophysical Journal, 932 (2). 133. ISSN 0004-637X

Abbott, R, Abbott, TD, Acernese, F et al. (1632 more authors) (2022) Search for gravitational waves associated with gamma-ray bursts detected by Fermi and Swift during the LIGO–Virgo run O3b. The Astrophysical Journal, 928 (2). 186. ISSN 0004-637X

Abbott, R, Abbott, TD, Acernese, F et al. (1624 more authors) (2022) Constraints on dark photon dark matter using data from LIGO’s and Virgo’s third observing run. Physical Review D, 105 (6). 063030. ISSN 2470-0010

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Giannetti, V orcid.org/0000-0001-5703-789X and Srinivasan, R (2021) The Cloud and its Silver Lining: Negative and Positive Spillovers from Automotive Recalls. Marketing Letters, 32 (4). pp. 397-409. ISSN 0923-0645

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736